The company has now raised $63 million to develop its AI-native MSK healthcare platform. Flagler will use the funding to expand its platform across musculoskeletal practices throughout the US. Funding Backs AI-Powered MSK CareFlagler Health has raised $50 million in Series B funding to expand its AI-native platform for musculoskeletal healthcare. The company plans to use the capital to expand its platform across musculoskeletal practices in the United States. Despite the size of the market, MSK practices continue to face fragmented systems and significant administrative workloads.